Fmoc-L-norvaline

Fmoc-L-norvaline is an N-(9H-fluoren-9-ylmethoxycarbonyl) protected L-norvaline amino acid, featuring a stereogenic alpha carbon consistent with the L-configuration and a side chain containing a straight-chain propyl group. The molecule bears a protected carboxyl functionality as a free acid form suitable for coupling chemistry, while the Fmoc carbamate masks the amino group and can be removed under base to regenerate the reactive amine for stepwise peptide assembly. The aromatic fluorenyl group provides strong UV/fluorescence detectability for analytical monitoring of protecting-group behavior, and the carbamate carbonyl enables predictable reactivity under standard peptide coupling conditions. As a chiral, protected amino acid building block, Fmoc-L-norvaline functions as a controlled intermediate for constructing norvaline-containing peptides and for generating side-chain-modified analogs through subsequent functional group transformations.

1. Peptide Synthesis

Fmoc-L-norvaline is applied in solid-phase peptide synthesis workflows where the Fmoc-protected amine supports iterative N-to-C coupling while preserving stereochemical integrity at the alpha center. The norvaline side chain provides a hydrophobic, aliphatic handle that can influence local conformational preferences in peptide backbones and can be retained or further derivatized after incorporation. Base-labile Fmoc deprotection enables sequential chain elongation, and the free carboxyl group participates in amide bond formation to install norvaline residues at defined positions. Downstream, norvaline-containing peptides prepared from this amino acid derivative can serve as standards, scaffold components, or substrate analogs in peptide chemistry and chemical biology research.

2. Protected Amino Acid Chemistry

Fmoc-L-norvaline is suitable for protected amino acid synthesis planning because the Fmoc carbamate provides a robust temporary protection strategy for the alpha-amino functionality during coupling and purification steps. The L stereochemistry and the unmodified aliphatic side chain reduce ambiguity in stereochemical outcomes and allow predictable incorporation into peptide building blocks and protected intermediate libraries. The Fmoc group can be removed to regenerate the free amine when switching between protected and reactive states, supporting orthogonal protection schemes that may include side-chain-protecting groups on other residues. The resulting norvaline derivative can be used as a chiral amino acid intermediate for fine chemical synthesis, including the preparation of peptide fragments and protected amino acid mixtures for process development.

3. Peptidomimetics And SAR

Fmoc-L-norvaline is used in peptidomimetic construction and structure-activity relationship studies where incorporation of a norvaline residue tunes hydrophobic surface area and backbone sterics relative to shorter or branched amino acids. The protected amino acid format enables controlled placement of the residue within peptide analogs, supporting systematic variation of side-chain length while maintaining a consistent coupling handle for library synthesis. The aliphatic propyl side chain can be retained to modulate binding interfaces or converted to functionalized analogs via post-assembly derivatization strategies, enabling exploration of structure-function relationships. Norvaline-containing analogs prepared from this building block can be applied as chemical probes, SAR series members, or reference compounds for analytical method development.

4. Chemical Biology Probes

Fmoc-L-norvaline is employed in chemical biology research as a residue source for generating peptide-based probes and molecular recognition reagents with defined stereochemistry. The Fmoc-protected amine and carboxyl functionality support construction of peptide tags, affinity ligands, or enzyme-binding motifs where the norvaline side chain contributes hydrophobic contacts and can affect membrane association tendencies of probe scaffolds. Fmoc deprotection and subsequent coupling enable modular assembly of probe sequences for downstream labeling or conjugation steps. Prepared probe constructs can be used to investigate biomolecular interactions through controlled chemical modification pathways that rely on amino acid chemistry and peptide science.

5. Pharmaceutical Manufacturing Intermediates

Fmoc-L-norvaline can be incorporated into pharmaceutical manufacturing-oriented workflows for producing peptide intermediates and defined peptide fragments used in downstream active ingredient synthesis or reference material preparation. The Fmoc-protected amino acid format supports scalable peptide coupling operations by providing a stable, isolable chiral building block with predictable deprotection behavior for chain assembly. The norvaline residue contributes an aliphatic hydrophobic segment that can be used to control solubility and aggregation tendencies in peptide sequences during manufacturing and formulation development. The compound's role as a chiral intermediate aligns with industrial fine chemical synthesis and specialty chemical production where protected amino acids are manufactured, qualified, and converted into peptide building blocks for further processing.

1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review

2. Effect of Probiotic Lactobacillus plantarum on Streptococcus mutans and Candida albicans Clinical Isolates from Children with Early Childhood Caries

3. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy

5. Zeta-potential-changing nanoparticles conjugated with cell-penetrating peptides for enhanced transfection efficiency